|1.||Gruber, Helen E: 1 article (01/2014)|
|2.||Hanley, Edward N: 1 article (01/2014)|
|3.||Sun, Yubo: 1 article (01/2014)|
|4.||Norton, Harry James: 1 article (01/2014)|
|5.||Zinchenko, Natalia: 1 article (01/2014)|
|6.||Franklin, Atiya M: 1 article (01/2014)|
|7.||Mauerhan, David R: 1 article (01/2014)|
|8.||Kristensen, Mette: 1 article (02/2007)|
|9.||Hels, Ole: 1 article (02/2007)|
|10.||Bügel, Susanne: 1 article (02/2007)|
01/01/1991 - "Serum-free gamma carboxyglutamic acid (free Gla) is a poor biochemical marker of bone resorption in early postmenopausal women."
12/01/2004 - "3. Among the 67 women who completed the study (24 on ISO, 24 on V, 19 on P), only ISO tablets were proven to decrease significantly urinary deoxypyridinoline (Dpd) excretion (P < 0.05 vs before), a specific biomarker of bone resorption, but there was no significant difference in serum bone gamma-carboxyglutamic acid-containing protein (BGP), a specific serum biomarker of bone formation. "
06/01/1985 - "The variables investigated were distal forearm bone mineral content (BMC), biochemical markers of bone formation: serum alkaline phosphatase and serum bone gamma-carboxyglutamic acid containing protein (BGP) and biochemical markers of bone resorption: fasting urinary calcium and fasting urinary hydroxyproline. "
02/01/2007 - "Serum bone-specific alkaline phosphatase as well as the urinary markers of bone resorption (N-telopeptide cross-links of collagen, pyridinoline and deoxypyridinoline) and urinary gamma-carboxyglutamate were unaffected by phylloquinone supplementation. "
|2.||Urinary Calculi (Urinary Calculus)
02/01/2001 - "Growing evidence suggests that most normal and tumor cells possess an active K1-dependent gamma-carboxylation mechanism necessary for the production of gamma-carboxyglutamic acid (Gla)-containing proteins. "
03/01/1993 - "Immunoreactivity for osteocalcin (human bone gamma-carboxyglutamic acid-containing protein) was demonstrated in most of these tumor cells. "
11/16/1982 - "Vitamin K dependent formation of gamma-carboxyglutamate residues in tumor microsomes."
11/01/1980 - "PTH responsiveness correlated with several properties, presumably associated with the osteoblastic phenotype: elevated alkaline phosphatase activity, synthesis of the gamma-carboxyglutamic acid-containing bone protein, and production of mineralized tumors in host rats. "
02/01/1984 - "It is suggested that this case of 'neoplasm-induced post-traumatic myositis ossificans' may be caused by the interaction of local haemorrhage and thrombosis, mucin-producing tumour implants, and the presence of large quantities of gamma-carboxyglutamic acid, an amino acid associated with the calcification of bone matrix formation."
|5.||Vitamin K Deficiency
09/01/1989 - "Effect of vitamin K deficiency on urinary gamma-carboxyglutamic acid excretion in rats."
04/01/1985 - "The assay system developed may be useful for the detection of vitamin K deficiency, since a severe deficiency may result in less gamma-carboxyglutamic acid residues in the protein."
03/01/1985 - "Vitamin K deficiency results in the appearance of abnormal prothrombin, deficient in gamma-carboxyglutamic acid, in the blood. "
12/01/1980 - "[Vitamin K and bone metabolism - on the effect of vitamin K deficiency and gamma-carboxyglutamic acid (author's transl)]."
09/01/1990 - "Chemical modification of gamma-carboxyglutamic acid (Gla) residues in human prothrombin to gamma-methyleneglutamic acid (gamma-MGlu) residues elicited a conformation similar, if not identical, to that of des-gamma-carboxy prothrombin or PIVKA-II, i.e., prothrombin molecules induced by vitamin K antagonists or vitamin K deficiency states. "
|6.||Proteins (Proteins, Gene)
|7.||Prothrombin (Factor II)
|2.||Renal Dialysis (Hemodialysis)